What is Johnson & Johnson's SG&A?

Johnson & Johnson (JNJ) reported SG&A of $6.03B in Q1 2026.

How has Johnson & Johnson's SG&A changed year-over-year?

Johnson & Johnson's SG&A increased by 18.0% year-over-year, from $5.11B to $6.03B.

What is the long-term trend for Johnson & Johnson's SG&A?

Over 4 years (2021 to 2025), Johnson & Johnson's SG&A has grown at a 4.2% compound annual growth rate (CAGR), from $20.12B to $23.68B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Johnson & Johnson JNJ SG&A

SG&A at other companies

AbbottABT

$3.74B+22.2%

Bristol-Myers SquibbBMY

$1.62B+2.1%

PfizerPFE

$2.96B-2.3%

Procter & GamblePG

$5.94B+7.5%

Merck & Co.MRK

$2.7B+5.8%

StrykerSYK

$2.28B-0.8%

Segments

By segment

See full

Innovative Medicine$2.92B+29.1%

MEDTECH$2.91B+9.4%

Other financials

Income statement

See full

Revenue$24.1B+9.9%

Gross profit$16.0B+9.8%

Operating income$6.3B+2.3%

Net income$5.2B-52.4%

EPS (diluted)$2.14-52.9%

Balance sheet

See full

Cash & equivalents$21.7B-43.6%

Total debt$55.0B+5.2%

Total equity$81.2B+3.9%

Total assets$200.89B+3.7%

Cash flow

See full

Operating cash flow$2.5B-39.8%

CapEx$1.0B+31.9%

Free cash flow$1.5B-56.6%

Valuation

See full

Market cap$589.48B+63.6%

Enterprise value$622.78B+66.4%

P/E28×+11.5×

P/S6.1×+2.1×

Profitability

See full

Gross margin67.8%-0.5pp

Operating margin26.4%+2.8pp

Net margin21.8%-2.6pp

FCF margin18.5%-4.3pp

Returns & leverage

See full

Return on equity26.4%-3.0pp

Debt / equity0.7×0.0×

Current ratio1×-0.2×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Johnson & Johnson's SG&A?: Johnson & Johnson (JNJ) reported SG&A of $6.03B in Q1 2026.
How has Johnson & Johnson's SG&A changed year-over-year?: Johnson & Johnson's SG&A increased by 18.0% year-over-year, from $5.11B to $6.03B.
What is the long-term trend for Johnson & Johnson's SG&A?: Over 4 years (2021 to 2025), Johnson & Johnson's SG&A has grown at a 4.2% compound annual growth rate (CAGR), from $20.12B to $23.68B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.